Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Garrison

Showing results (101-110 of 316) with videos related to

Pageof 32
Sort By:
Journal of Medical Economics|May 14, 2019
Determinants of specialist physician ambulatory visits: a neurology exampleDavid N van der Goes, John P Ney, Louis P Garrison
Journal of Pain & Palliative Care Pharmacotherapy|December 21, 2017
Prevalence of and Comorbid Health Conditions Associated With Pediatric Prescription Opioid Use in the USSouvik Banerjee, Carl L Roland, Richard Willke, et al.
Molecular Neurodegeneration|January 8, 2011
6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell deathAlison I Bernstein, Sean P Garrison, Gerard P Zambetti, et al.
International Journal of Dermatology|June 1, 1995
Basal cell carcinoma and lifestyle characteristicsW J Sahl, S Glore, P Garrison, et al.
Occupational and Environmental Medicine|May 1, 1994
A case-control study of chronic neuropsychiatric disease and organic solvent exposure in automobile assembly plant workersN A Nelson, T G Robins, R F White, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]Louis P Garrison, Mark V Pauly, Richard J Willke, et al.
AANNT Journal|October 1, 1983
The use of rehabilitation services by patients with chronic renal failure: results from the National Kidney Dialysis and Kidney Transplantation StudyR W Evans, D L Manninen, L P Garrison, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 1, 2023
A review of economic issues for gene-targeted therapies: Value, affordability, and accessLouis P Garrison, Andrew W Lo, Richard S Finkel, et al.
BMC Medicine|January 29, 2024
Is the price right? Paying for value today to get more value tomorrowSreeram V Ramagopalan, Jose Diaz, Grace Mitchell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 24, 2008
The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancerJosh J Carlson, Louis P Garrison, Scott D Ramsey, et al.
Pageof 32

Showing results (101-110 of 316) with videos related to

Sort By:
Pageof 32
Journal of Medical Economics|May 14, 2019
Determinants of specialist physician ambulatory visits: a neurology exampleDavid N van der Goes, John P Ney, Louis P Garrison
Journal of Pain & Palliative Care Pharmacotherapy|December 21, 2017
Prevalence of and Comorbid Health Conditions Associated With Pediatric Prescription Opioid Use in the USSouvik Banerjee, Carl L Roland, Richard Willke, et al.
Molecular Neurodegeneration|January 8, 2011
6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell deathAlison I Bernstein, Sean P Garrison, Gerard P Zambetti, et al.
International Journal of Dermatology|June 1, 1995
Basal cell carcinoma and lifestyle characteristicsW J Sahl, S Glore, P Garrison, et al.
Occupational and Environmental Medicine|May 1, 1994
A case-control study of chronic neuropsychiatric disease and organic solvent exposure in automobile assembly plant workersN A Nelson, T G Robins, R F White, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]Louis P Garrison, Mark V Pauly, Richard J Willke, et al.
AANNT Journal|October 1, 1983
The use of rehabilitation services by patients with chronic renal failure: results from the National Kidney Dialysis and Kidney Transplantation StudyR W Evans, D L Manninen, L P Garrison, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 1, 2023
A review of economic issues for gene-targeted therapies: Value, affordability, and accessLouis P Garrison, Andrew W Lo, Richard S Finkel, et al.
BMC Medicine|January 29, 2024
Is the price right? Paying for value today to get more value tomorrowSreeram V Ramagopalan, Jose Diaz, Grace Mitchell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 24, 2008
The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancerJosh J Carlson, Louis P Garrison, Scott D Ramsey, et al.
Pageof 32